title: User acceptability and perceived benefits of new reports in CareLink Pro 3.0 Therapy Management Software for Diabetes.
authors.forename: John B
authors.initials: JB
authors.lastname: Welsh
authors.forename: Samantha J
authors.initials: SJ
authors.lastname: Myers
authors.forename: Abby N
authors.initials: AN
authors.lastname: Uhrinak
authors.forename: Francine R
authors.initials: FR
authors.lastname: Kaufman
authors.forename: Scott W
authors.initials: SW
authors.lastname: Lee
mesh_terms: D001291:Attitude of Health Personnel; D001292:Attitude to Computers; D015415:Biomarkers / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation*; D003920:Diabetes Mellitus / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000175:diagnosis / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects; D007332:Insulin Infusion Systems; D008991:Monitoring, Physiologic / Q000295:instrumentation*; D011237:Predictive Value of Tests; D012815:Signal Processing, Computer-Assisted; D012984:Software; D011795:Surveys and Questionnaires; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin